About Timothy Walbert
Timothy Walbert is a director at Latigo Biotherapeutics.
Timothy Walbert reports to the SEC as a director or officer of 17 public companies, including Kardigan (KARD), Mirum Pharmaceuticals (MIRM) and Biomarin Pharmaceutical (BMRN).
Timothy Walbert first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Walbert in the role, so the role may have started earlier or lasted longer.
KI
Kardigan, Inc.
Director
2026 · Public company (KARD)
MI
Mirum Pharmaceuticals, Inc.
Director
2023 – 2026 · Public company (MIRM)
BI
Biomarin Pharmaceutical Inc.
Director
2025 – 2026 · Public company (BMRN)
OI
CI
Century Therapeutics, Inc.
Director
2022 – 2025 · Public company (IPSC)
SI
Sagimet Biosciences Inc.
Director
2024 – 2025 · Public company (SGMT)
HC
Horizon Therapeutics Public Ltd Co
Chairman, President and CEO
2011 – 2023 · Public company (HZNP)
AI
Aurinia Pharmaceuticals Inc.
Director
2021 – 2022 · Public company (AUPH)
EI
Exicure, Inc.
Director
2019 – 2021 · Public company (XCUR)
AI
Assertio Holdings, Inc.
Director
2020 · Public company (ASRT)
ZS
Zyla Life Sciences
Director
2014 – 2020 · Public company (ZCOR)
SI
Sucampo Pharmaceuticals, Inc.
Director
2015 – 2018 · Public company (SCMP)
XC
XOMA Royalty Corp
Director
2010 – 2017 · Public company (XOMA)
RC
Raptor Pharmaceutical Corp
Director
2011 – 2014 · Public company (RPTP)
II
Idm Pharma, Inc.
President and CEO, director
2007 – 2008 · Public company (IDMI)
NI
Neopharm Inc.
Ex. VP - Commercial Operations
2006 · Public company (NEOL.PK)
Key Colleagues at Startups
The people Timothy Walbert works with at each company, as listed on that company's latest Form D.
Latigo Biotherapeutics, Inc. · Form D, Feb 13, 2025
NS
Nancy Stagliano
Director
BS
Beth Seidenberg
Director
NF
Nima Farzan
Executive officer and director
JT
Jim Tananbaum
Director
DP
Deborah Palestrant
Director
KR
Kevin Raidy
Director
TL
Tim Lugo
Chief Financial Officer